Metabolic Syndrome in Early Onset Versus Late Onset Vitiligo
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Central obesity as a Metabolic risk in vitiligo patients
研究概览
简要总结
This study aims at detection of possible associated metabolic syndrome with vitiligo and assessment of possible contribution of the age of onset of vitiligo.
详细描述
This study aims at detection of incidence of metabolic syndrome in vitiligo patients and possible contribution of the age of onset of the disease. This involves detection of waist circumference, body mass index, index of central obesity, systolic and diastolic arterial blood pressure, fasting blood sugar, high density lipoproteins and triglycerides, in addition to insulin resistance as Homeostatic Model Assessment- insulin resisitance (HOMA-IR) and serum leptin in vitiligo patients. The outcomes will be correlated to extent/ severity/duration/ activity of vitiligo as well as to the age of onset. This is assumed to be of profound impact on vitiligo patients by properly assessing these patients for associated metabolic risk factors and helping prevent such metabolic derangements by detection of possible contributing factors such as insulin resistance and high serum adipokines as leptin.
Since there is temporal relation between nutrition, metabolic derangements and skin diseases where nutritional deficiencies as minerals, vitamins and fatty acids can lead to cutaneous manifestations and , on the other hand; skin diseases could contribute to metabolic derangements and nutritional deficiencies, the investigator's study will focus on nutrition and dietary habits and there possible contribution to any associated metabolic risk in vitiligo patients.
This is likely to open new horizons in the management of vitiligo, possibly through control of metabolic syndrome risk factors and insulin resistance as well as revealing possible temporal relation to dietary habits that are overlooked in vitiligo patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Both genders
- •Patients with non-segmental vitiligo (NSV) and segmental vitiligo
排除标准
- •Pregnancy
- •Systemic steroid intake in the last 6 months
结局指标
主要结局
Central obesity as a Metabolic risk in vitiligo patients
时间窗: one year
Central obesity will be assessed using waist circumference in cm in vitiligo patients and control group as a risk factor for metabolic syndrome
次要结局
- Arterial Blood Pressure as a Metabolic risk in vitiligo patients(one year)
- Serum Triglycerides and HDL(one year)
- Detection of insulin resistance in patients with vitiligo(one year)
- Correlation between extent/ severity/duration/ activity of vitiligo and possible associated metabolic derangements.(one year)
- Detection of possible influence of dietary habits and its relation to metabolic derangements and disease progression(one year)
- Body mass index as a Metabolic risk in vitiligo patients(one year)
- Fasting Blood pressure as a Metabolic risk in vitiligo patients(one year)
- Correlation between extent/ severity/duration/ activity of vitiligo and the age of onset.(one year)
研究者
Rania Mogawer
Principal investigator
Cairo University
